Trial intelligence / Profile preview

Inhaled treatment trial for prematurity-associated airway obstruction and inflammation

2015-003712-20Phase 4Completed

Sponsor
Cardiff University
Start
Nov 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of fluticasone propionate and salmeterol in Airway Obstruction (AO) and airway inflammation (4 arms), sponsored by Cardiff University. Started Nov 2019; status: completed.

02

Drugs

fluticasone propionatesalmeterol
03

Conditions

Airway Obstruction (AO)airway inflammation

Beyond the preview

Go deeper on 2015-003712-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003712-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call